3,882
edits
Changes
Jump to navigation
Jump to search
Line 12:
Line 12: − + + + + + + +
no edit summary
#Gene-specific pages (for example see [[ABL1]])
#Gene-specific pages (for example see [[ABL1]])
*For more details on how you use the site to be an author, please see an instructional video (see section below).
*For more details on how you use the site to be an author, please see an instructional video (see section below). Of note, we highly encourage authors to populate all the tables (i.e. for immunophenotype, chromosomal rearrangements, genomic gain/loss/LOH, etc) when applicable.
*For the timeline, there’s some flexibility and please work with your Associate Editor to set a target date.
*For the timeline, there’s some flexibility and please work with your Associate Editor to set a target date.
*Once a page is complete, please:
1. Delete the statement "This page is under construction. We need you help! Please consider joining in the project and submitting a review".
2. Email the appropriate Associate Editor that the page is complete.
*Trainees are highly encouraged and welcome to participate in this effort. Trainees are asked to work with a mentor to help review their page content before completion.
*Trainees are highly encouraged and welcome to participate in this effort. Trainees are asked to work with a mentor to help review their page content before completion.
*For any additional questions, please contact us at CCGA@cancergenomics.org. If applicable, please include the disease category you are interested in working on in the subject line (''i.e.'' ALL, mature B-cell neoplasms, etc).
*For any additional questions, please contact us at CCGA@cancergenomics.org. If applicable, please include the disease category you are interested in working on in the subject line (''i.e.'' ALL, mature B-cell neoplasms, etc).